The Male Attenuation Spectrum (MAS)
A taxonomic framework for the systematic suppression of male biological function.
Overview
The Male Attenuation Spectrum (MAS) is a classification system describing how many seemingly isolated forces of modern society converge into an overarching framework of diminished or suppressed masculine function. These span chemical, pharmacological, surgical, cultural, dietary, and behavioural domains — degrading male endocrine function, autonomic regulation, sexual capacity, and psychological sovereignty.
Some of these forces are commercially driven. Some are culturally inherited. Some operate at an unconscious level due to lack of informed consent. Many are normalised to the point of invisibility.
Individually, each vector is documented. Collectively, they have never been mapped as a unified system. The spectrum aims to give a clear name to the state they produce — essentially, a state of stolen potential.
The overarching term for the aggregate system is The Suppression Axis.
Documented Vectors
| Domain | Vector | Mechanism | Documented Consequence |
|---|---|---|---|
| Chemical | Microplastics & xenoestrogens (BPA, phthalates, atrazine) | Endocrine disruption via estrogenic receptor binding | Reduced testosterone, reproductive toxicity, declining sperm counts |
| Estrogenic pharmaceutical runoff in water supply | Chronic low-dose exogenous estrogen exposure via municipal water | Hormonal interference, feminisation markers in aquatic and human populations | |
| Seed oils & phytoestrogens | Omega-6 inflammatory loading, estrogenic compound ingestion | Systemic inflammation, hormonal disruption | |
| Pharmacological | SSRIs → Post-SSRI Sexual Dysfunction (PSSD) | Serotonergic suppression of sexual function; persistent receptor changes post-discontinuation | Genital anaesthesia, anhedonia, libido extinction — persisting indefinitely after cessation |
| Finasteride / DHT blockers → Post-Finasteride Syndrome (PFS) | Neurosteroid disruption (allopregnanolone depletion); autonomic dysregulation | Freeze-state locking, genital tissue changes, cognitive impairment, anhedonia | |
| Statins | Cholesterol pathway suppression → reduced steroidogenic precursor availability | Testosterone reduction, fatigue, cognitive effects | |
| Antipsychotics & opioids | Dopaminergic suppression, prolactin elevation, HPA axis disruption | Libido extinction, hormonal disruption, sexual dysfunction | |
| Surgical | Infant calibration | Neonatal nervous system trauma during peak neuroplasticity; excision of primary sensory tissue; freeze-response imprinting | Autonomic vulnerability priming, altered pain processing, reduced sexual sensitivity, compliance template establishment |
| Dietary | Ultra-processed food & refined sugar | Chronic insulin spiking, systemic inflammation, gut microbiome disruption | Metabolic dysfunction, brain fog, hormonal interference, reduced energy |
| Artificial additives & preservatives | Endocrine-active compounds in food supply | Cumulative low-grade toxic load | |
| Behavioural | Pornography | Dopaminergic hijacking via supernormal stimuli; intimacy substitution | Desensitisation, erectile dysfunction, reduced pair-bonding capacity |
| Chronic dopamine dysregulation (social media, gaming, gambling) | Sustained overstimulation of reward circuitry | Motivation collapse, anhedonia, inability to pursue high-effort goals | |
| Sedentary lifestyle | Reduced blood flow, metabolic stagnation, hormonal suppression | Lower testosterone, poor autonomic tone, increased inflammation | |
| Cultural | Chronic stress normalisation | Sustained sympathetic dominance; cortisol loading | Parasympathetic suppression, hormonal disruption, autonomic inflexibility |
| Identity fragmentation | Erosion of coherent masculine framework via cultural messaging | Psychological atomisation, reduced agency, vulnerability to external definition | |
| Lack of initiation or rites of passage | No structured transition from boy to man in modern culture | Arrested development, perpetual adolescence, absence of sovereign identity |
The Compounding Effect
Each vector in the spectrum lowers the threshold at which subsequent vectors become pathological. This is the defining feature of MAS — it is not a list of separate problems. It is a compounding system.
Endocrine disruption reduces hormonal resilience. Pharmacological intervention suppresses neurosteroid production. Surgical trauma during peak neuroplasticity primes the autonomic system toward freeze-state vulnerability. Dietary degradation undermines metabolic function. Behavioural vectors hijack the reward system. Cultural conditioning normalises the resulting dysfunction and redirects compensatory behaviour into consumption.
No single vector needs to be catastrophic on its own. The convergence is the mechanism. The normalisation is the delivery system.
Why It Has No Name
Each vector in MAS is studied in isolation. Endocrinologists document xenoestrogen exposure. Neurologists document SSRI withdrawal syndromes. Urologists document calibration complications. Psychologists document pornography-induced dysfunction. Nobody maps the overlap. Nobody names the pattern.
This is not incidental. Systems that benefit from male attenuation — pharmaceutical markets, surgical economies, attention-capture industries — have no incentive to name the convergence. The absence of a name has been, until now, its most effective defence.
MAS provides the name.
Protocols on This Site
Post-Finasteride Syndrome modelled as autonomic dysregulation rather than endocrine damage. Demonstrates how neurosteroid disruption locks the nervous system into chronic freeze state.
Bilateral Pelvic Oscillation Technique. A somatic intervention targeting the autonomic freeze state produced by MAS vector convergence.
Documents how infant calibration establishes autonomic vulnerability during peak neuroplasticity, priming the system for subsequent vector loading.
M1 — The Sovereign Ascendant
The counter-framework to MAS is documented separately: M1 — The Sovereign Ascendant.